The use of chromogranin, synaptophysin and islet amyloid polypeptide as markers for neuroendocrine tumours.
Stridsberg
M
M
Department of Clinical chemistry, University Hospital, Uppsala, Sweden.
D000682:Amyloid / Q000097:blood* / Q000652:urine; D014408:Biomarkers, Tumor / Q000097:blood* / Q000652:urine; D015153:Blotting, Western; D002276:Carcinoid Tumor / Q000097:blood* / Q000652:urine; D018273:Carcinoma, Islet Cell / Q000097:blood* / Q000652:urine; D002864:Chromogranins / Q000097:blood* / Q000652:urine; D006801:Humans; D007124:Immunoenzyme Techniques; D058228:Islet Amyloid Polypeptide; D010190:Pancreatic Neoplasms / Q000097:blood* / Q000652:urine; D011863:Radioimmunoassay; D016708:Synaptophysin / Q000097:blood* / Q000652:urine
D000682:Amyloid; D014408:Biomarkers, Tumor; D002864:Chromogranins; D058228:Islet Amyloid Polypeptide; D016708:Synaptophysin